Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
1.2.1. Neuralgia Treatment Market, by Region, 2018-2027 (USD Billion)
1.2.2. Neuralgia Treatment Market, by Treatment, 2018-2027 (USD Billion)
1.2.3. Neuralgia Treatment Market, by End-User, 2018-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Neuralgia Treatment Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Neuralgia Treatment Market Dynamics
3.1. Neuralgia Treatment Market Impact Analysis (2018-2027)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Neuralgia Treatment Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model (2017-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Neuralgia Treatment Market, by Treatment
5.1. Market Snapshot
5.2. Global Neuralgia Treatment Market by Treatment, Performance - Potential Analysis
5.3. Global Neuralgia Treatment Market Estimates & Forecasts by Treatment 2017-2027 (USD Billion)
5.4. Neuralgia Treatment Market, Sub Segment Analysis
5.4.1. Drug Based
5.4.2. Surgery
Chapter 6. Global Neuralgia Treatment Market, by End-User
6.1. Market Snapshot
6.2. Global Neuralgia Treatment Market by End-User - Potential Analysis
6.3. Global Neuralgia Treatment Market Estimates & Forecasts by End-User 2017-2027 (USD Billion)
6.4. Neuralgia Treatment Market, Sub Segment Analysis
6.4.1. Hospitals & Clinics
6.4.2. Ambulatory Surgery Center
6.4.3. Others
Chapter 7. Global Neuralgia Treatment Market, Regional Analysis
7.1. Neuralgia Treatment Market, Regional Market Snapshot
7.2. North America Neuralgia Treatment Market
7.2.1. U.S. Neuralgia Treatment Market
7.2.1.1. Treatment breakdown estimates & forecasts, 2017-2027
7.2.1.2. End-User breakdown estimates & forecasts, 2017-2027
7.2.2. Canada Neuralgia Treatment Market
7.3. Europe Neuralgia Treatment Market Snapshot
7.3.1. U.K. Neuralgia Treatment Market
7.3.2. Germany Neuralgia Treatment Market
7.3.3. France Neuralgia Treatment Market
7.3.4. Spain Neuralgia Treatment Market
7.3.5. Italy Neuralgia Treatment Market
7.3.6. Rest of Europe Neuralgia Treatment Market
7.4. Asia-Pacific Neuralgia Treatment Market Snapshot
7.4.1. China Neuralgia Treatment Market
7.4.2. India Neuralgia Treatment Market
7.4.3. Japan Neuralgia Treatment Market
7.4.4. Australia Neuralgia Treatment Market
7.4.5. South Korea Neuralgia Treatment Market
7.4.6. Rest of Asia Pacific Neuralgia Treatment Market
7.5. Latin America Neuralgia Treatment Market Snapshot
7.5.1. Brazil Neuralgia Treatment Market
7.5.2. Mexico Neuralgia Treatment Market
7.6. Rest of The World Neuralgia Treatment Market
Chapter 8. Competitive Intelligence
8.1. Top Market Strategies
8.2. Company Profiles
8.2.1. GlaxoSmithKline PLC
8.2.1.1. Key Information
8.2.1.2. Overview
8.2.1.3. Financial (Subject to Data Availability)
8.2.1.4. Product Summary
8.2.1.5. Recent Developments
8.2.2. Pfizer Inc.
8.2.3. Novartis AG
8.2.4. Biogen Inc.
8.2.5. Cadila Healthcare Limited
8.2.6. Lundbeck Pharmaceuticals LLC
8.2.7. Allergan Plc
8.2.8. Merz Pharma GmbH & Co.
8.2.9. Trigemina Inc.,
8.2.10. Abbott Laboratories
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption